GB2023586B - Taurine derivatives - Google Patents

Taurine derivatives

Info

Publication number
GB2023586B
GB2023586B GB7920953A GB7920953A GB2023586B GB 2023586 B GB2023586 B GB 2023586B GB 7920953 A GB7920953 A GB 7920953A GB 7920953 A GB7920953 A GB 7920953A GB 2023586 B GB2023586 B GB 2023586B
Authority
GB
United Kingdom
Prior art keywords
taurine derivatives
taurine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB7920953A
Other versions
GB2023586A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorio Chimico Farmaceutico Causyth SpA
Original Assignee
Laboratorio Chimico Farmaceutico Causyth SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Chimico Farmaceutico Causyth SpA filed Critical Laboratorio Chimico Farmaceutico Causyth SpA
Publication of GB2023586A publication Critical patent/GB2023586A/en
Application granted granted Critical
Publication of GB2023586B publication Critical patent/GB2023586B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
GB7920953A 1978-06-15 1979-06-15 Taurine derivatives Expired GB2023586B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT24587/78A IT1096662B (en) 1978-06-15 1978-06-15 TAURINIC DERIVATIVES FOR ANTI-LIPEMIC AND CHOLERETIC ACTIVITIES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM

Publications (2)

Publication Number Publication Date
GB2023586A GB2023586A (en) 1980-01-03
GB2023586B true GB2023586B (en) 1982-08-04

Family

ID=11214073

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7920953A Expired GB2023586B (en) 1978-06-15 1979-06-15 Taurine derivatives

Country Status (9)

Country Link
JP (2) JPS5943942B2 (en)
BE (1) BE876969A (en)
DE (1) DE2901046C3 (en)
ES (3) ES476812A1 (en)
FR (2) FR2465717A1 (en)
GB (1) GB2023586B (en)
IT (1) IT1096662B (en)
LU (1) LU81379A1 (en)
NL (1) NL7904644A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1126575B (en) * 1979-12-07 1986-05-21 Causyth Chim Farm COMPOUND WITH ANTI-INFLAMMATORY, ANALGESIC AND ANTI-PIRETIC ACTIVITY, PROCESS FOR ITS PREPARATION, AND RELATED PHARMACEUTICAL COMPOSITIONS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR920312A (en) * 1944-08-01 1947-04-03 Ward Process for the preparation of nicotic acid derivatives
GB586453A (en) * 1944-08-01 1947-03-19 Ward Blenkinsop & Co Ltd Process for the production of derivatives of nicotinic acid
CH520697A (en) * 1970-03-03 1972-03-31 Sopharma Sa Process for the preparation of a nicotinic acid ester-amide

Also Published As

Publication number Publication date
FR2511365A1 (en) 1983-02-18
DE2901046B2 (en) 1981-07-16
JPS554381A (en) 1980-01-12
FR2465717A1 (en) 1981-03-27
DE2901046C3 (en) 1982-05-06
JPS6133171A (en) 1986-02-17
FR2511365B1 (en) 1985-03-15
IT7824587A0 (en) 1978-06-15
ES482484A1 (en) 1980-04-01
NL7904644A (en) 1979-12-18
JPS5943942B2 (en) 1984-10-25
DE2901046A1 (en) 1979-12-20
ES476812A1 (en) 1979-12-16
ES482483A1 (en) 1980-04-16
IT1096662B (en) 1985-08-26
BE876969A (en) 1979-10-01
GB2023586A (en) 1980-01-03
LU81379A1 (en) 1979-09-12

Similar Documents

Publication Publication Date Title
GB2033893B (en) Tetrazolylalkoxycarbostyril derivatives
IL61507A0 (en) Pyridinesulfonylisocyanate derivatives
ZA793543B (en) 2-chloro-6-nitroaniline derivatives
GB2012759B (en) Thienohydantoin derivatives
PH15672A (en) Spiro-polycyclicimidazolidinedione derivatives
GB2022079B (en) L-leucyl-4-hydroxyanilide derivatives
IL56430A0 (en) Prostaglanding derivatives
IL56702A0 (en) Aldamolamine derivatives
GB2038326B (en) Acylaniline derivatives
GB2018757B (en) 3-phenyltetrahydropyridine derivatives
GB2017708B (en) Steroid-spirooxazolidinone derivatives
GB2036744B (en) Eburnane derivatives
GB2017691B (en) 2-hydroxymethyl-pyrazine derivatives
GB2019843B (en) N-alkenylmoranoline derivatives
ZA787312B (en) Arylaminoimidazoline derivatives
GB2024806B (en) Onomycin derivatives
GB2052477B (en) Carbamoyl-piperazine derivatives
GB2013187B (en) Phenylpyrol derivatives
GB2023574B (en) N-cyano-azomethine derivatives
PT69794A (en) Sephalosporin derivatives
PH14560A (en) Oxadiazolothiazine derivatives
GB2023586B (en) Taurine derivatives
GB2037764B (en) 7-methoxycepgalosporin derivatives
GB2013654B (en) Benziosothiazole derivatives
GB2044251B (en) Phenoxypropanolamine derivatives

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee